XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 26.70

-0.8%

Jan 23 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: aknahow who wrote (9090)	3/10/1999 11:44:00 PM
From: Cacaito	Read Replies (1) of 17367

Part of the protocol (refreshing): www3.techstocks.com Notice the that at the time they were already talking about going from 100 to 300 patients. Nothing about the dose. But meningo PI/II used three doses, all effective (no placebo group). Intrabdominal infections open label trial (PI/II) used 3 doses, higher doses (no placebo group) showed trend to work better. If several doses regimen are used then the trial needs more patients, vs a single dose trial. Phase I/II purposes are to try to establish the most appropriate dose/doses for phase III.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next